LONG-ACTING INJECTABLE BROMOCRIPTINE DOES NOT REDUCE RELAPSE IN ALCOHOLICS
Saved in:
NARANJO, C.A., ET AL., LONG-ACTING INJECTABLE BROMOCRIPTINE DOES NOT REDUCE RELAPSE IN ALCOHOLICS. ADDICTION, Vol. 92, no. 8 (1997), p. 969-978.
Ref.
61715
Location:
SIIS R.696
Palabras clave:
Alcoholismo, Drogodependencias, Fármacos, Prevención, Recaída, Resultados, Tratamiento
Alcoholismo, Drogodependencias, Fármacos, Prevención, Recaída, Resultados, Tratamiento
Similar Items: LONG-ACTING INJECTABLE BROMOCRIPTINE DOES NOT REDUCE RELAPSE IN ALCOHOLICS
- BROMOCRIPTINE REDUCES CIGARETTE SMOKING
- NEWLY APPROVED NALTREXONE CAN HELP REDUCE CRAVING AND PREVENT RELAPSE
- RELAPSE PREVENTION: AN EMERGING TECHNOLOGY FOR PROMOTING LONG-TERM DRUG ABSTINENCE
- ACAMPROSATE AND PREVENTION OF RELAPSE IN ALCOHOLICS
- AMIRACLE FOR THE CHRONIC RELAPSER?
- TREATMENT OF COCAINE-ALCOHOL DEPENDENCE WITH NALTREXONE AND RELAPSE PREVENTION THERAPY